Natural killer (NK) cells play a key role in the immune response to certain infections and malignancies by direct cytolysis of infected or transformed cells and by secretion of potent immune mediators. NK cells express an array of activating receptors that recognize self-molecules. If not restrained by inhibitory receptors recognizing major histocompatibility complex (MHC) class I proteins on the surface of self cells, NK cells are able to kill normal, healthy cells. Not all NK cells express inhibitory receptors for self-MHC class I; thus, other tolerance mechanisms are necessary to prevent NK cellmediated autoimmunity. Here we review the major mechanisms of NK cell education and tolerance.
Natural killer (NK) cells are the third population of lymphoid cells that, unlike T and B cells, do not express receptors that require somatic gene rearrangements to generate receptor diversity and specificity. Instead, NK cell functions are controlled by a wide array of germline-encoded inhibitory and activating receptors, many of which are expressed in a stochastic, variegated pattern, resulting in many subsets of functionally distinct NK cells. Although normally classified as part of the innate immune system due to the lack of receptor gene rearrangement, it has recently been appreciated that NK cells exhibit many features normally associated with adaptive immunity. These include the expansion of pathogen-specific cells, the generation of long-lasting ''memory'' cells that persist after cognate antigen encounter, and the ability to mount an enhanced secondary recall response to rechallenge (Sun et al., 2009 ). Although NK cell-associated receptors have been implicated in certain autoimmune diseases (Gur et al., 2010; Martin et al., 2002; Namekawa et al., 2000; Yen et al., 2001) , and NK cells may alter T cell-mediated autoimmunity (Feuerer et al., 2009; Lu et al., 2007; Poirot et al., 2004; Shi et al., 2000) , as yet there is no evidence that NK cells alone are able to directly cause autoimmunity. Even on autoimmune-prone genetic backgrounds such as NOD, autoimmune disease is not observed in these mouse strains in the absence of B cells and T cells. Thus, NK cell education and tolerance appear to be more effective than either the central or peripheral tolerance mechanisms governing T cells and B cells that can fail, causing autoimmunity.
Many of the activating or coactivating NK cell receptors expressed by mouse and human NK cells recognize self-antigens (Table 1) . For example, the activating NKG2D receptor recognizes numerous self-ligands in the host. Several of the activating Killer-cell Immunoglobulin-like Receptor (KIR), Ly49, and CD94-NKG2C receptors are capable of recognizing self-major histocompatibility complex (MHC) class I proteins, and members of the ''natural cytotoxicity receptors'' group (such as NKp30, NKp44, and NKp46) appear able to bind as yet undefined selfligands in the host (Lanier, 2008; Moretta et al., 2001 ). In addition, several ''coactivating'' receptors have been identified on NK cells, such as CD2, LFA-1, CD244 (2B4), and CD226 (DNAM-1), which also recognize self-ligands that are broadly distributed on many tissues in the host (Lanier, 2008) . Thus, NK cells express many activating receptors for self that could potentially drive autoreactivity.
NK Cell Receptors for MHC Class I
Although NK cells express a wide variety of inhibitory receptors that recognize diverse self-molecules to prevent autoaggression, inhibitory NK receptors recognizing self-MHC class I are considered to be the predominant mechanism responsible for NK cell tolerance to self. This is most dramatically demonstrated by the ability of NK cells in wild-type, healthy mice to rapidly reject splenocytes or bone marrow from syngeneic mice lacking the MHC component b2-microglobulin (b2 m, an MHC component), MHC class I heavy chains, or TAP-1 Dorfman et al., 1997; Liao et al., 1991; Ljunggren et al., 1994) . This finding implies that healthy hematopoietic cells from wildtype mice constitutively express ligands for activating NK receptors that can initiate a strong NK cell response, if not restrained by the expression of MHC class I on healthy lymphoid or myeloid cells (Dong et al., 2009) .
Three families of NK receptors recognize MHC class I: the primate KIR, the murine Ly49 receptors, and the CD94-NKG2 receptors in both rodents and primates. All three gene families encode both inhibitory and activating family members (Long, 2008) . The activating receptors in the human KIR and murine Ly49 families arose by gene duplication and conversion from inhibitory receptors (Abi-Rached and Parham, 2005) , such that the extracellular domains of these activating receptors are highly homologous to their inhibitory counterparts ( Figure 1A ). Therefore, several of the activating KIR and Ly49 receptors have the ability to bind with low affinity to MHC class I ligands.
All of the inhibitory receptors in humans and rodents contain one or more intracellular immunoreceptor tyrosine-based inhibitory motifs (ITIM), which are characterized by the signature sequence (I/L/V/S)xYxx (L/V) (where x represents any amino acid, and slashes separate alternative amino acids that may occupy a given position). Many of the activating receptors lack intracellular signaling motifs but instead noncovalently associate via a charged residue in the receptor transmembrane domain with the immunoreceptor tyrosine-based activating motif (ITAM)-containing adapters DAP12, Fc3RIg, or CD3z, which recruit and activate the Syk or ZAP70 tyrosine kinases, or in some cases the DAP10 adaptor, which induces PI3-kinase signaling ( Figure 1A) . With a few exceptions, human KIRs contain either two (KIR2D) or three (KIR3D) immunoglobulin (Ig)-like domains in the extracellular domain and are designated as KIR2DL or KIR3DL, respectively, if they possess a long cytoplasmic domain containing ITIM. KIR2DS or KIR3DS have short cytoplasmic domains lacking ITIM but possess charged residues in their transmembrane regions to allow for association with DAP12 or Fc3RIg. KIR2D receptors typically recognize human leukocyte antigen -C (HLA-C) alleles, whereas KIR3D receptors recognize HLA-B or some HLA-A alleles. The NKG2 family contains one inhibitory family member, NKG2A, and two activating members, NKG2C and NKG2E. The inhibitory CD94-NKG2A and the activating CD94-NKG2C receptors both recognize MHC class Ib molecules, either HLA-E in humans or its ortholog Qa-1 in mice (Lanier, 2005) . In humans, a subset of NK cells express another KIR-related inhibitory receptor, LILRB1 (also designated LIR-1, CD85j, or ILT2), which recognizes a shared epitope present in all human MHC class I proteins (Chapman et al., 1999) .
Chronic Exposure to Activating Ligands Tolerizes NK Cells Given the existence of numerous activating receptors that can interact with host-encoded ligands, how do NK cells avoid causing autoimmunity? In mice, the Rae-1 family of NKG2D ligands is constitutively expressed in the embryo but is silenced before birth and is not expressed or is expressed in only low amounts in healthy adult tissues. Immunocompetent adult mice reject transplanted tumors expressing NKG2D ligands and eliminate virus-infected cells in which NKG2D ligands are induced (Cerwenka et al., 2001; Diefenbach et al., 2001; Lodoen et al., 2003 Lodoen et al., , 2004 . NK cells efficiently reject adoptively transferred syngeneic hematopoietic cells from mice constitutively expressing a Raet1 transgene, encoding a ligand for the activating NKG2D receptor. These findings indicate that NK cells have the capacity to recognize and attack otherwise normal, healthy cells if they express NKG2D ligands (Ogasawara et al., 2005; Oppenheim et al., 2005) . In contrast, NK cells in Rae-1 transgenic mice do not attack Rae-1-bearing tissues and are unable to reject transplanted tumors expressing NKG2D ligands . Thus, when NK cells develop in the continuous presence of NKG2D ligands they tolerate cells expressing these ligands, due to both the downregulation of the NKG2D receptor on the NK cells as well as hyporesponsiveness to NKG2D signaling . Studies examining NK cells from transgenic mice constitutively expressing Rae-1 have found that activating NK receptors other than NKG2D may or may not be impaired depending on the particular ligand expressed, its distribution, and its abundance Ogasawara et al., 2005; Oppenheim et al., 2005; Wiemann et al., 2005) . In vitro coculture of mouse NK cells with NKG2D ligand-bearing tumors can also desensitize other activating receptors on the NK cells (Coudert et al., 2008 (George et al., 1999) . Although the molecular mechanisms of this tolerance or receptor anergy are undefined, it has been suggested that it is mediated by the coexpression of the H-2D d -reactive inhibitory receptors Ly49A and Ly49G2 (George et al., 1999) . Similarly, there is no direct evidence that human NK cells expressing activating KIR with the ability to recognize self-HLA-C ligands cause autoimmunity in these individuals, although a genetic association between activating KIR and certain autoimmune diseases has been reported but might be caused by expression of activating KIR on T cells (Kulkarni et al., 2008) . Another activating Ly49 receptor, Ly49H, recognizes a mouse cytomegalovirus (MCMV)-encoded glycoprotein, m157, but does not recognize host MHC class I ligands (Arase et al., 2002; Smith et al., 2002) . MCMV m157 also binds the inhibitory Ly49I receptor and thus likely evolved to inhibit NK cell responses to MCMV infection. The gene encoding Ly49H arose from the duplication of the gene encoding Ly49I and conversion to an activating receptor by swapping the ITIM-bearing domain for a charged transmembrane domain ( Figure 1B ). Although beneficial for controlling MCMV, this Ly49H precursor might have potentially been autoreactive due to its specificity for MHC class I. Further selection events eliminated this self-reactivity, while retaining MCMV specificity ( Figure 1B ). Whereas Ly49H-expressing NK cells from wild-type mice respond robustly when they encounter MCMV-infected cells, ubiquitous transgenic or retroviral expression of m157 in mice renders the Ly49H-expressing NK cells unresponsive to Ly49H stimulation (Sun and Lanier, 2008b; Tripathy et al., 2008) . This is caused, in part, by downmodulation of the Ly49H receptor on the NK cells encountering m157 during development, but also by hyporesponsiveness of receptor signaling. Whether or not chronic stimulation through Ly49H affects signaling through other activating receptors may depend on the amount of ligand expressed or the anatomical location of the expressed ligand (Sun and Lanier, 2008b; Tripathy et al., 2008) . In these systems, anergy is induced in NK cells transferred from non-m157-expressing hosts into the transgenic animal, indicating that anergy can be induced in mature NK cells (Tripathy et al., 2008) . The m157 did not need to be expressed by the developing NK cells themselves as expression of m157 in trans is sufficient to impair Ly49H functions (Sun and Lanier, 2008b) . Collectively, these studies demonstrate that NK cells, like T cells, achieve a state of tolerance when they are chronically exposed to endogenous, as well as foreign, ligands recognized by their activating receptors. Unlike T cells, which only express a single dominant-activating receptor, chronic exposure to one activating ligand may tolerize NK responses only to the cognate receptor or alternatively to other activating receptors on the same cells, depending on the system. The mechanisms of this receptor-proximal tolerance and whole-cell anergy are not yet defined.
Do NK Cells Undergo Selection of Inhibitory Receptor Repertoires?
The inhibitory KIR and Ly49 receptors recognize polymorphic variants on their MHC class I ligands. Within the total NK cell population, the inhibitory receptors for MHC class I are (A) New activating receptors for natural killer cells are generated by duplication of an inhibitory receptor gene and the subsequent conversion to an activating receptor. This conversion occurs when the exons for the transmembrane (TM) and intracellular domains are exchanged with those of an activating receptor by crossover events. If the new activating receptor is specific for self-major histocompatibility complex (MHC) class I, it might cause autoimmunity and be selected against. (B) Inhibitory receptors that are specific for both MHC class I and pathogen-encoded ligands have also been converted to activating receptors. Subsequent mutations have eliminated the specificity for MHC class I and retained specificity for the pathogen-encoded ligand.
expressed in a variegated manner on overlapping subsets of NK cells. Moreover, the inhibitory KIR and Ly49 receptors themselves are highly polymorphic and have differing affinities for their MHC class I ligands (Carlyle et al., 2008; Hanke et al., 1999; Parham, 2008) . These features, as well as the fact that the NK receptors and their MHC class I ligands are not genetically linked, result in a situation where some NK cells in the host do not express an inhibitory receptor for any self-MHC class I protein. Indeed, we now appreciate that in some individuals a significant proportion of NK cells fail to express inhibitory receptors reactive with the polymorphic MHC class I molecules that they have inherited (Fernandez et al., 2005; Yawata et al., 2008 ). Yet, these individuals do not suffer from autoimmune attack by their NK cells, raising the question of how NK cells lacking self-MHC class I inhibitory receptors achieve tolerance.
Some strains of rodents possess 20 or more Ly49 genes and some humans possess 15 KIR genes, providing for considerable receptor diversity within the NK cell population. Expression of these receptors appears stochastic and NK cells can express many KIR or Ly49 receptors that do not bind to self-MHC class I ligands in the host. Therefore, the presence of a MHC class I ligand is not required for NK cells to stably express a given Ly49 or KIR on a substantial subset of cells. In addition, NK cells expressing an activating KIR or Ly49 receptor that is able to bind MHC class I, in general, are not deleted or preferentially expanded in a host possessing a reactive MHC class I allele. Therefore, unlike in T cells, there is no evidence for either strong positive or negative selection of NK cells with respect to the activating KIR or Ly49 receptors.
Nonetheless, the expression of self-ligands for the inhibitory NK receptors for MHC class I does influence the development of NK cells. The frequency of NK cells expressing multiple inhibitory receptors can be approximately predicted by multiplying the frequency of NK cells expressing each inhibitory receptor Valiante et al., 1996) . Although this ''product rule'' roughly holds for MHC class I-deficient mouse models, expression of two or more inhibitory receptors for self-MHC class I occurs less frequently than would be expected in MHC class I-sufficient mice. In fact, the frequency of NK cells expressing MHC class I-reactive inhibitory receptors is higher in MHC class I-deficient animals than in MHC class I-sufficient animals (Held et al., 1996; Salcedo et al., 1997) . Thus, it appears that there is a selective or educational event that limits the expression of two or more inhibitory receptors for self-MHC class I on a given NK cell. The expression of MHC class I on both hematopoietic and nonhematopoietic cells influences the development of the inhibitory Ly49 repertoire (Roth et al., 2000; Sykes et al., 1993) . Transgenic expression of an inhibitory Ly49 receptor limits the expression of endogenous Ly49 receptors in vivo, suggesting that engagement with self-MHC class I prevents subsequent expression of new inhibitory receptors during development (Held and Raulet, 1997) . Therefore, there is an as yet undefined mechanism to ensure that NK cells do not express too many inhibitory receptors for self-MHC class I (Hanke et al., 2001; Held and Raulet, 1997; . Similarly, human NK cell interactions with self-HLA class I ligands shape the inhibitory KIR repertoire in an individual (Shilling et al., 2002; Yawata et al., 2006 Yawata et al., , 2008 .
NK Cell Education Mediated by Self-MHC Class I and Inhibitory Receptors
An early study reported that all human NK cell clones from two individuals expressed at least one inhibitory receptor that recognized a self-MHC class I protein, suggesting that a selective process shaped the NK cell repertoire to maintain tolerance (Valiante et al., 1997) . However, as mentioned above, recent studies have detected a significant number of mature NK cells in humans and mice in vivo that do not express any inhibitory receptors for MHC class I or only express receptors that recognize non-self MHC class I (Fernandez et al., 2005; Yawata et al., 2008) . Additionally, mice lacking surface expression of MHC class I due to genetic ablation of b2-microglobulin, TAP-1, and/or MHC class I heavy chains H-2K and H-2D have normal numbers of mature NK cells and do not exhibit overt NK cellmediated autoimmunity.
NK cells developing in the absence of MHC class I are unable to kill MHC class I-deficient tumor cell lines in vitro and fail to reject MHC class I-deficient bone marrow in vivo Jonsson and Yokoyama, 2009; Liao et al., 1991) . In MHC class I-sufficient humans or mice, the subset of NK cells lacking inhibitory receptors for self-MHC class I are hyporesponsive to in vitro stimulation through several activating receptors and fail to reject MHC class I-deficient bone marrow in vivo (Anfossi et al. The Basis for NK Cell Inhibition, Education, and Tolerance NK cell education requires signaling via the inhibitory receptors because mutations within the ITIM of inhibitory receptors render NK cells hyporesponsive even in the presence of the cognate MHC class I ligand of the mutant receptor (Kim et al., 2005) . Two mechanisms have been proposed to explain this tolerance of NK cells lacking self-MHC class I. The first hypothesis postulates that NK cells are initially unresponsive or ''unlicensed'' and that MHC class I engagement of inhibitory receptors during development licenses or ''arms'' these cells to become competent effector cells (Kim et al., 2005) . Alternatively, the ''disarming'' hypothesis suggests that all NK cells are initially responsive, but if unopposed by MHC class I-specific inhibitory receptors chronic stimulation by normal cells renders NK cells anergic (Gasser and Raulet, 2006) .
In mixed bone marrow chimeras generated with MHC class I-sufficient and b2 m-deficient bone marrow, all of the NK cells were hyporesponsive (Wu and Raulet, 1997 only expressed on 10%-80% of hematopoietic cells) were unable to reject C57BL/6 bone marrow or kill C57BL/6 lymphoblasts (Johansson et al., 1997) . Thus, NK cell education requires the educating MHC class I to be expressed on all cells or alternatively hyporesponsiveness is dominantly induced by lack of MHC class I, as would be predicted by the disarming hypothesis. The SHP-1 and SHIP-1 phosphatases associated with inhibitory receptor signaling are dispensable for NK education, suggesting that inhibitory signals are not needed for NK cell education, supporting the licensing model (Kim et al., 2005; Orr et al., 2010) . However, these findings are not incompatible with the disarming model because many inhibitory receptors also associate with SHP-2, so there might be signaling redundancy between the different phosphatases recruited by the inhibitory receptors. A third ''rheostat'' model proposes that NK cell reactivity is tuned by the number of self-MHC class I inhibitory receptors an NK cell expresses and by the affinity of each receptor for self-MHC class I Raulet and Vance, 2006) . NK cells that express two or more inhibitory receptors for self-MHC class I respond more frequently and possess stronger effector functions than NK cells with only one inhibitory receptor for self-MHC class I Joncker et al., 2009) . The affinity of the interaction between the inhibitory receptor and its MHC class I ligand also influences the NK cell education process (Jonsson et al., 2010) . Thus, NK cell education is likely to be a quantitative process whereby NK cell responsive capacity is determined by the frequency and strength of engagement of inhibitory receptors with self-MHC class I, either opposing chronic activating receptor stimulation (disarming) or by transmitting undefined activating signals themselves (licensing or arming). Unlike T cells, there is no evidence for efficient clonal deletion of potentially autoreactive NK cells either during development in the bone marrow or in the periphery. Rather, NK cells lacking self-MHC class I reactive inhibitory receptors are maintained in an unresponsive state-at least in the absence of inflammation or infection.
Inhibitory Receptors Can Bind to MHC Class I on the Same Cell Surface In mice, inhibitory receptors appear to be expressed at lower levels if cognate MHC class I is expressed. This has been interpreted as calibrating of the inhibitory receptors to a useful level (Sentman et al., 1995) . Inhibitory Ly49 receptors can, however, bind to MHC class I expressed on the same cell surface (binding in cis) as well as binding to MHC class I on other cells (in trans) (Back et al., 2009; Doucey et al., 2004; Scarpellino et al., 2007) . Disrupting cis interactions restores apparent levels of these inhibitory receptors to that detected on MHC class I-deficient NK cells, providing evidence against the calibration model, rather implying that cis interactions simply mask the antibody-binding site necessary to detect the inhibitory Ly49 receptor (Doucey et al., 2004) . These cis interactions have been proposed to mediate NK cell licensing because mutant inhibitory receptors incapable of cis interactions are unable to engender NK cell responsiveness (Chalifour et al., 2009 ). However, results from mixed wild-type and b2 m-deficient bone marrow chimeras demonstrate that disarming of wildtype NK cells is dominant in the chimeras and is induced in trans, thus arguing against licensing in cis (Wu and Raulet, 1997) . Cis interactions do prevent inhibitory receptor recruitment to the immunological synapse, thus reducing the inhibitory potential of these receptors (Andersson et al., 2007; Doucey et al., 2004) .
Breaking NK Cell Anergy and Tolerance
Just as anergized or exhausted T cells can often regain functionality by ex vivo cytokine stimulation or by blocking the tolerizing signal (Barber et al., 2006; Teague et al., 2006) , functionality of unlicensed or disarmed NK cells can be restored. This restoration of function can be accomplished in a number of ways, including in vitro culture with interleukin-2 (IL-2) or with IL-12 and IL-18, strong stimulation via activating receptors in vitro, or infection with Listeria monocytogenes or MCMV in vivo (Fernandez et al., 2005; Johansson et al., 1997; Kim et al., 2005; Orr et al., 2010; Sun and Lanier, 2008a; Yokoyama and Kim, 2006) . After MCMV infection, licensed and unlicensed NK cells, as defined by self-MHC class I inhibitory receptor expression, both express the early activation antigen CD69 and equivalently upregulate effector molecules such as interferon-g (IFN-g) and granzyme B (Orr et al., 2010) . This early activation is driven by the inflammatory environment associated with infection and is independent of cognate activating receptor engagement. During MCMV infection NK cells in C57BL/6 mice undergo a proliferative burst, driven by the activating Ly49H receptor engaging its cognate ligand, the MCMV-encoded glycoprotein m157, which is expressed on the surface of infected cells (Dokun et al., 2001) . Expression of inhibitory receptors for self-MHC class I restrain the proliferation of licensed NK cells, whereas in NK cells lacking self-MHC reactive inhibitory receptors proliferation proceeds unimpeded (Orr et al., 2010) . This restraint of proliferation by inhibitory receptors is mediated by SHP-1 phosphatase signaling. NK cells are critical for controlling MCMV viral titers and pathogenesis, yet depletion of licensed NK cells does not negatively affect control of MCMV. Similarly, adoptive transfer of unlicensed, but not licensed, NK cells is sufficient to protect neonates against MCMV challenge (Orr et al., 2010) . Thus, when NK cells need to directly interact with virus-infected cells to control the infection, inhibitory receptors for MHC class I impair, rather than license, NK cell functions ( Figure 2B ).
In mixed bone marrow chimeric mice containing b2 m-deficient and wild-type hematopoietic cells, the NK cell tolerance demonstrated by the wild-type NK cells can also be broken during viral infection. In these chimeric mice, b2 m-deficient hematopoietic cells, which were largely tolerated for weeks or months, are rapidly eliminated by NK cells after viral infection (Sun and Lanier, 2008a (Johansson et al., 1997) .
NK cell anergy in response to chronic stimulation to m157 could be reversed if the Ly49H-expressing NK cells are removed from the m157 transgenic mice, indicating that anergy requires sustained exposure to the activating ligand (Tripathy et al., 2008) . Collectively, these findings reveal that NK cell tolerance or anergy is reversible and broken in the presence of inflammatory cytokines or infection.
NK Cell Inhibitory Receptors and Control of Human Leukemias
In human leukemia patients receiving irradiation therapy followed by bone marrow transplantation, donor NK cells can play a critical role in eliminating residual leukemic cells and preventing rejection of the donor bone marrow by killing recipient antigen-presenting cells that normally prime allogeneic T cell responses. In T cell-depleted, HLA-matched, but KIR-mismatched bone marrow transplants (in which not all donorderived NK cells are inhibited by the recipient HLA or educated by donor or recipient HLA), the number of inhibitory KIR-HLA mismatches (that is, missing inhibitory ligands in the recipient) correlates with positive outcomes, including fewer leukemic relapses and improved graft acceptance (Clausen et al., 2007; Hsu et al., 2005; Sobecks et al., 2007; Symons et al., 2010) . Donor-derived NK cells in the bone marrow recipient that are unlicensed (that is, do not express KIR reactive with donor or recipient HLA class I) ex vivo express high levels of IFN-g and are competent to kill target cells, indicating that they are activated effector cells (Yu et al., 2009) . Reciprocally, in HLAmismatched, T cell-depleted bone marrow grafts, positive outcomes correlate with lack of HLA ligands in the recipient for inhibitory KIRs on donor-derived NK cells (Miller et al., 2007; Ruggeri et al., 2002) . Thus, in the case of NK cell-mediated graft-versus-leukemia, expression of inhibitory KIRs on donorderived NK cells that are reactive with recipient HLA limited the effectiveness of donor NK cells in clearing leukemias and promoting graft acceptance .
NK Cell Inhibitory Receptors in Immune Defense
In the absence of infection or inflammation, NK cells that possess inhibitory receptors for self-MHC class I are more responsive to stimulation than NK cells lacking self-MHC class I inhibitory receptors. Under what circumstances might these NK cells with self-MHC class I receptors provide benefit to the host? One scenario would be when host cells become transformed and downregulate MHC class I expression due to chromosomal instability that results in the loss of b2 m, TAP-1, or MHC class I heavy chain genes. The ability of healthy mice to reject transplanted cells from syngeneic b2 m-deficient mice clearly demonstrates that as yet undefined ligands for activating NK receptors are present on nontransformed host cells, but NK cell attack is being prevented by the inhibitory receptors for self-MHC class I.
Although not yet experimentally demonstrated, the NK cells that possess inhibitory receptors for self-MHC class I might provide for ''missing-self'' detection and elimination of nascent tumors. Another scenario whereby NK cells that possess inhibitory receptors for self-MHC class I might be beneficial is in sparing MHC class I-expressing dendritic cells from attack by NK cells during an infection. In the absence of NK cells or in mice lacking the Ly49H receptor, a stronger T cell response is mounted against MCMV infection. This may be due to a robust early NK cell response that eliminates MCMV-infected dendritic cells, thus decreasing priming of MCMV-specific T cells (Andrews et al., 2010; Su et al., 2001) . Although not tested in this study, it is possible that dendritic cells are preferentially killed by Ly49H + NK cells lacking self-MHC class I inhibitory receptors. Thus, by restraining NK cell responses, inhibitory receptors might contribute to better overall control of infection by permitting more robust T cell priming.
What Prevents Autoimmunity Mediated by NK Cells?
In steady-state conditions, NK cells lacking self-MHC class I inhibitory receptors might simply be anergized by chronic stimulation through their unknown activating receptors engaging ligands on normal cells and tissues. However, both in vivo and in vitro these NK cells can be activated by cytokines or infection and mediate potent effector functions. What then might regulate their attack against normal, healthy cells or tissues? In addition to inhibitory receptors for MHC class I, NK cells express several other inhibitory receptors that recognize ligands not encoded by MHC genes (Kumar and McNerney, 2005) (Table 2 ). Many of these inhibitory receptors are expressed constitutively on most NK cells. For example, mouse 2B4 (CD244) recognizes the ubiquitously expressed CD48 glycoprotein, human NKR-P1A (CD161) recognizes the LLT1 ligand on activated B cells and dendritic cells, and human and mouse LAIR-1 (CD305) recognizes collagen. Other receptors such as KLRG1 that recognizes cadherins and gp49B1 that recognizes the a v b 3 integrin are upregulated on activated NK cells during viral infection (Robbins et al., 2004; Wang et al., 2000) . The role of these inhibitory receptors in shaping NK cell tolerance and functionality is largely unexplored, particularly in regulating the subset of NK cells lacking self-MHC class I inhibitory receptors. Thus, these inhibitory receptors might prevent NK cell-driven autoimmunity. Alternatively, elimination of uninfected cells (bystander killing) by NK cells lacking MHC class I-reactive inhibitory receptors might be an evolutionarily acceptable trade-off for the enhanced control of infections ( Figure 2C ).
Outstanding Questions
Although NK cells have been studied for more than 30 years and many of their receptors and signaling pathways have been identified, the molecular basis of NK cell tolerance remains undefined. Strikingly, we still do not know the physiological relevance of ''missing self'' surveillance in the host. Another major unsolved question is how NK cells lacking self-reactive MHC class I inhibitory receptors can functionally mature and acquire lytic effector molecules yet remain tolerant of their environment. Finally, the mechanisms inducing tolerance upon chronic exposure to activating ligands are undefined. These and many other questions need to be answered before we can fully understand NK cell development, education, and tolerance. Andrews, D.M., Estcourt, M.J., Andoniou, C.E., Wikstrom, M.E., Khong, A., Voigt, V., Fleming, P., Tabarias, H., Hill, G.R., van der Most, R. G., et al. (2010) . Innate immunity defines the capacity of antiviral T cells to limit persistent infection. J. Exp. Med. 207, 1333 -1343 Anfossi, N., Andre, P., Guia, S., Falk, C.S., Roetynck, S., Stewart, C.A., Breso, V., Frassati, C., Reviron, D., Middleton, D., et al. (2006) . Human NK cell education by inhibitory receptors for MHC class I. Immunity 25, 331-342.
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